Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No doubt about it. We finally have the trading vehicle that will allow for the plans made so many years ago to be implemented. It’s been a heck of a ride.
Perfectly stated...
Float getting tighter everyday....
The trick is to buy, go long and reap massive gains when a major Biotech/Pharma buys us out…Look at the history, if you didn’t know, it often repeats…. If you want to fool around trading 100k shares good luck. LTI’s keep sweeping up the the 500k offers when they are available . Those offers will soon disappear. Pay attention.
7/22/2022 Press : News: Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets
SEATTLE, WA, July 22, 2022 (GLOBE NEWSWIRE) -- Institute of Biomedical Research Corp. (OTC Pink: MRES), a diversified biomedical company, announces the purchase of biomedical and nutraceutical assets from Wuhan General Group (China), Inc in an all-cash transaction ("Purchase'').
"This purchase is a perfect match to our business model and supports both our strategy in this sector and our direction to continue to create a path for success for our shareholders," said Kim Halvorson, Director of the Board of Institute of Biomedical Research Corp.
As part of the Purchase, the Institute of Biomedical Research Corp in an all-cash transaction will assume current liabilities related to the assets which include the following four companies ("Assets''):
M2Bio Sciences Food and Beverage Proprietary Limited has a range of nutritional food and beverage products that are stocked by more than 100 stores in South Africa. M2Bio Sciences also conducts research into sustainable products using primarily hemp and mycelium and is developing various cosmetics and complementary medicines using plant-based active ingredients.
Neurai Life Sciences Proprietary Limited focuses on research into the application of plant-based and other non-invasive therapies to treat depression, addiction, and other major afflictions of the 21st century.
Tsime Pharmaceutical and Medical Supplies (Proprietary) Limited has a license to cultivate, process, and export cannabis for medicinal, scientific and any other legal use.
MJMedtech Inc is registered in Canada and currently dormant.
"It was important to identify a dynamic group of companies that complement the mission of the Institute of Biomedical Research Corp. The management team coming across with the acquired companies has a solid history of achievement and credentials to take the Institute of Biomedical Research Corp. to success,'' said Kim Halvorson.
Ms. Kim Halvorson has stepped down as Chief Executive Officer and appointed Mr. Jeff Robinson as the new Chief Executive Officer, and a Director of the company. All current management and employees of Wuhan operating companies will be retained. The Company will adhere to OTC Markets and SEC guidelines for Best Practices for Disclosure and Transparency.
"We are delighted to move forward with our research and technology under the Institute of Biomedical Research Corp. Both companies have the same objectives of bringing innovation and products to the healthcare industry,'' stated Jeff Robinson.
About Institute of Biomedical Research Corporation
The Institute of Biomedical Research is a biomedically ambitious business venture whose activities extend from highly diversified scientific research and sophisticated services combining the latest science and naturally occurring compounds and extracts. The Company looks to expand its major long-term biomedical and environmental research projects, as well as development of new diagnostic technologies and innovative experimental medical treatments. The research of new therapies and biomedical products also constitutes important business activities of the Institute. The Institute is essential for the development of Montenegro within the regional and European environment. This is now with new offices in the Biotech Research Center of the Pacific Northwest, South Lake Union, Seattle Washington.
Publicly traded company (OTC Pink: MRES)
Website: www.mrescorp.com
About Wuhan General Group, (China) Inc.
Wuhan General Group, Inc., through its wholly-owned subsidiary MJ MedTech is a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research that develops and commercializes a range of CBD and mushrooms-based products under Dr. AnnaRx™, Medspresso™, and Liviana™ brands. In addition, our research and clinical trials with psilocybin are aimed at new therapies that will help patients who suffer from alcohol addiction, mental illness, and cardiovascular diseases. Our mission is to advance botanical-based medicine to the forefront by deploying best-practice science and medicine, clinical research, and emerging technologies.
Publicly traded company (OTC Pink: WUHN)
Visit Website: https://m2bio.co
Forward-Looking Statements
Safe Harbor Statement - In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company's future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company's business units or the market price of its common stock. Additional factors that could cause actual results to differ materially from those contemplated within this press release can also be found on the Company's website. The Company disclaims any responsibility to update any forward-looking statements.
For more information, press only:
Institute of Biomedical Research Corp.
PR CONTACT: Kim Halvorson
info@mrescorp.com
https://mrescorp.com/
Source: Institute of Biomedical Research Corp.
https://www.globenewswire.com/news-release/2022/07/22/2484276/0/en/Institute-of-Biomedical-Research-Corp-Announces-Purchase-of-Biomedical-and-Nutraceutical-Assets.html
Shares remain scarce and 1 of these days ahead we'll begin ascending through dimeland with big boys initiating their full-fledged accumulation wave tick tick tick tick tick...
Agreeeeeeeeed LTT, rig providin' another multi-month BEAST to the masses \m/
Slowly but surely every single early profit taker continues getting replaced by investment grade hands woot-woot>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
What’s the trick to getting more than just a couple of trades a day here? Smh
Hope Yall $ee MRES GOING TO Dollar$
RIG laid it all out at .01 when Jeff took over this shell...
just read this few times too......
Lottalead
Member Level
Re: learningthetruth post# 7710
Wednesday, September 14, 2022 10:47:13 PM
Post#
7715
of 7718
I’ve been looking back at Portage Biotech and who was involved in the build out of that company that made millions for investors..
As we know, Portage was a reverse merge into Bontan corp. owned by the Robinson brothers… they were the founding partners along with Billionaire’s Dr. Bailey and Jim Mellon.. so who else was in on it?… ..John Robinson, brother and M2Bio investor Sheldon was among some of the chosen few who got in early… check it out..
Current Capital is owned 100% by Mr. John Robinson. Mr. Robinson is a selling shareholder with respect to 4,444,000 shares and 1,040,000 warrant shares owned by Current Capital Corp. Mr. Robinson owns 18% of our outstanding capital stock as of September 30, 2006. Current Capital is a media relations company and provides services to us
5
Sheldon Inwentash (5)
130 King Street West, Suite 2810
Toronto, ON M5X 1A9
Canada
7,612,000
25.12%
6,000,000
-
-
14
John D. Robinson (14)
47 Avenue Road, Suite 200
Toronto, ON M5R 2G3
Canada
5,545,199
18%
4,440,000
https://docoh.com/filing/1095435/0001168981-06-000043/PRTG-F3
The point is that this same template is being used here. They will manage the share structure, they will raise the funds that they need in a PP to the chosen few . Then they will build another Biotech Giant with NeuraiLife Sciences and spin out the other companies. At what point will the good Dr. B and J.M. step up?
Here is another clue,,,
?? Upcoming Events:
MASTER INVESTOR SECTOR FOCUS:
Going for Gold
Join us on 21st September for a webinar focused on gold. With global uncertainty has come a renewed interest in the precious metal and we’ll discuss the gold outlook with major investor, Jim Mellon. Master Investor will host four gold companies with exciting projects in development to help keep our investors ahead of the curve.
21 September 2022 | London | 1:30pm – 3:30pm
https://internetbullreport.com/the-weekly-bull-report-september-11-2022-??/
Looks like Jeff will be traveling again very soon to see his buddy Jim..
Post of the Year there Lotta!!!
Gonna sticky that one.....INCREDIBLE DD BROTHER there......You and RIG nailed it!!!
What's to come is powerful....Very Powerful...
Incredible post again LOTTA, thanks for the Incredible DD and Sharing!!!
Been watching. What are next steps or catalysts at this point
So….in a nut shell…BOOYAH!
Lol
I’ve been looking back at Portage Biotech and who was involved in the build out of that company that made millions for investors..
As we know, Portage was a reverse merge into Bontan corp. owned by the Robinson brothers… they were the founding partners along with Billionaire’s Dr. Bailey and Jim Mellon.. so who else was in on it?… ..John Robinson, brother and M2Bio investor Sheldon was among some of the chosen few who got in early… check it out..
Current Capital is owned 100% by Mr. John Robinson. Mr. Robinson is a selling shareholder with respect to 4,444,000 shares and 1,040,000 warrant shares owned by Current Capital Corp. Mr. Robinson owns 18% of our outstanding capital stock as of September 30, 2006. Current Capital is a media relations company and provides services to us
5
Sheldon Inwentash (5)
130 King Street West, Suite 2810
Toronto, ON M5X 1A9
Canada
7,612,000
25.12%
6,000,000
-
-
14
John D. Robinson (14)
47 Avenue Road, Suite 200
Toronto, ON M5R 2G3
Canada
5,545,199
18%
4,440,000
https://docoh.com/filing/1095435/0001168981-06-000043/PRTG-F3
The point is that this same template is being used here. They will manage the share structure, they will raise the funds that they need in a PP to the chosen few . Then they will build another Biotech Giant with NeuraiLife Sciences and spin out the other companies. At what point will the good Dr. B and J.M. step up?
Here is another clue,,,
?? Upcoming Events:
MASTER INVESTOR SECTOR FOCUS:
Going for Gold
Join us on 21st September for a webinar focused on gold. With global uncertainty has come a renewed interest in the precious metal and we’ll discuss the gold outlook with major investor, Jim Mellon. Master Investor will host four gold companies with exciting projects in development to help keep our investors ahead of the curve.
21 September 2022 | London | 1:30pm – 3:30pm
https://internetbullreport.com/the-weekly-bull-report-september-11-2022-??/
Looks like Jeff will be traveling again very soon to see his buddy Jim..
SHHH .. MRES GOING TO DOLLARS BUDS. CEO SOLIDIFIES IT.
Yes it’s looking much better now
Moving up and buyin out weak hands
LOL, just sell and move on.......
BHVN, PRTG......I'm up nicely from my .012 average....
Trying doing some DD on the above......last post to U.....
How do they work, then? Because so far their stock sucks.
Not a chance. That’s not how this management team works.
None and None … lol
So where’s the volume? Any news due out soon?
I’m in as well. Let’s get this party started
Yep, and same with O/S...transferred to Preferred....
One of the best to hold on OTC IMHO and especially give market conditions....
Those will be adjusted and some cancelled as they roll out IMO
I didn’t realize this had 10 billion authorized shares. Yikes
Thank you Iceman buddy! Always an amazing sign to see you vested in one of these burgeoning BEASTS:)
Welcome aboard doogdilinger!
Agreed 10th, strong silent type here haha glty!
MRES one of the best investment grade plays out there with miles & miles of upside still coming choo-choo:)
One of the best post labor day madness plays available LTT. Gonna be an epic & colossal 4th Q here choo-choo>>>$$$$$$$$$$$$$$$$$$$$$$$$$$$
Thanks , let’s see this puppy grow $$$ MRES
Welcome aboard pmunch!
ICE
Hope we recoup our loss !!
MRES
Need to hear more about the EFC connection to MRES
Could be a start … getting ready to run - MRES
Need to add a few this week to catch up
$ MRES
Thats a good thing. Most of us here came over from wuhn...
This board is very quiet
$MRESFiling! Just saw this. https://www.otcmarkets.com/otcapi/company/financial-report/346406/content
So what’s the story here? Nice close
Big buyer in the tape.......Wowsa....
Little more volume and we'll clear all the .02's....
Loading more today... taking advantage of any dips here! Looking for an update, so we can really see some action. GLTA
Agreed 220%!!
We've been patient!!
Followers
|
127
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
9648
|
Created
|
04/20/07
|
Type
|
Free
|
Moderators jdcpa1 Iceman GREGG THE GREEK LUCKYBUTT |
Unit 1 Masons Press Building
7 Ravenscraig Road
Woodstock, Cape Town 7925
South Africa
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |